These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 34169093)
1. Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures. Zhang C; Ding J; Xu X; Liu Y; Huang W; Da L; Ma Q; Chen S Front Mol Biosci; 2021; 8():645024. PubMed ID: 34169093 [No Abstract] [Full Text] [Related]
2. Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer. Zhang H; Song J; Dong J; Liu Z; Lin L; Wang B; Ma Q; Ma L Front Genet; 2021; 12():551605. PubMed ID: 33732281 [No Abstract] [Full Text] [Related]
3. Identifying prognostic signatures in the microenvironment of prostate cancer. Lu G; Cai W; Wang X; Huang B; Zhao Y; Shao Y; Wang D Transl Androl Urol; 2021 Nov; 10(11):4206-4218. PubMed ID: 34984186 [TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment characterization in colorectal cancer to identify prognostic and immunotherapy genes signature. Guo XW; Lei RE; Zhou QN; Zhang G; Hu BL; Liang YX BMC Cancer; 2023 Aug; 23(1):773. PubMed ID: 37596528 [TBL] [Abstract][Full Text] [Related]
5. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253 [TBL] [Abstract][Full Text] [Related]
6. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
8. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer. Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X Front Immunol; 2022; 13():1056932. PubMed ID: 36479114 [TBL] [Abstract][Full Text] [Related]
9. Immunity and Extracellular Matrix Characteristics of Breast Cancer Subtypes Based on Identification by T Helper Cells Profiling. Zhou Y; Tian Q; Gao H; Zhu L; Zhang Y; Zhang C; Yang J; Wang B Front Immunol; 2022; 13():859581. PubMed ID: 35795662 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer. Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507 [TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a dysregulated TME-related gene signature for predicting prognosis, and immunological properties in bladder cancer. Shen C; Chai W; Han J; Zhang Z; Liu X; Yang S; Wang Y; Wang D; Wan F; Fan Z; Hu H Front Immunol; 2023; 14():1213947. PubMed ID: 37965307 [TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures. Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225 [TBL] [Abstract][Full Text] [Related]
13. Improving ovarian cancer treatment decision using a novel risk predictive tool. Xu Z; Song J; Cao L; Rong Z; Zhang W; He J; Li K; Hou Y Aging (Albany NY); 2022 Apr; 14(8):3464-3483. PubMed ID: 35439731 [TBL] [Abstract][Full Text] [Related]
14. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma. Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP Front Oncol; 2022; 12():1094248. PubMed ID: 36620592 [TBL] [Abstract][Full Text] [Related]
15. Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer. Chen J; Liu Z; Wu Z; Li W; Tan X Front Oncol; 2023; 13():1132424. PubMed ID: 37251940 [TBL] [Abstract][Full Text] [Related]
16. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling. Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801 [TBL] [Abstract][Full Text] [Related]
17. TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine. Zhang S; Wan X; Lv M; Li C; Chu Q; Wang G EPMA J; 2022 Sep; 13(3):519-534. PubMed ID: 36061829 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced Long Non-coding RNA LSAMP-AS1 Regulates ceRNA Network to Predict Prognosis for Pancreatic Cancer. Li L; Zou W; Xiao Z; Deng Z; Liu R Comb Chem High Throughput Screen; 2023; 26(13):2358-2371. PubMed ID: 36918789 [TBL] [Abstract][Full Text] [Related]
19. 5-methylcytosine RNA methylation regulators affect prognosis and tumor microenvironment in lung adenocarcinoma. Liu T; Hu X; Lin C; Shi X; He Y; Zhang J; Cai K Ann Transl Med; 2022 Mar; 10(5):259. PubMed ID: 35402591 [TBL] [Abstract][Full Text] [Related]
20. An investigation to identify tumor microenvironment-related genes of prognostic value in lung squamous cell carcinoma based on The Cancer Genome Atlas. Liu H; Liu B; Zhang L; Li M; Chen C; He S; Luo T; He X; Tan L Transl Cancer Res; 2021 Apr; 10(4):1885-1899. PubMed ID: 35116510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]